Press Releases

December 18, 2013 • 6:00 AM EST

Amarantus Licenses MANF-Related Wolfram's and Diabetes Therapeutic and Diagnostic Intellectual Property From University of Massachusetts Medical School

December 17, 2013 • 9:54 AM EST

Amarantus and Brewer Sports Announce ONE MIND for Research at 2nd #C4CT Concussion Awareness Summit Prior to Super Bowl XLVIII at United Nations

December 3, 2013 • 8:00 AM EST

Amarantus Obtains Exclusive Option to License University of Miami Bascom Palmer Eye Institute's Intellectual Property for the Treatment of Retinal Diseases Using MANF and CDNF

November 26, 2013 • 9:19 AM EST

Amarantus BioScience to Present at the LD Micro Sixth Annual Conference on December 3, 2013

November 14, 2013 • 4:15 PM EST

Amarantus Reports Third Quarter 2013 Financial Results and Development Progress

November 13, 2013 • 10:16 AM EST

Amarantus and Brewer Sports Announce 2nd #C4CT Concussion Awareness Summit Surrounding Super Bowl XLVIII

November 6, 2013 • 7:30 AM EST

Amarantus Appoints David A. Lowe, PhD to Board of Directors

October 30, 2013 • 11:31 AM EDT

Amarantus Relocates Headquarters to Janssen Labs @QB3 Incubator in San Francisco

October 16, 2013 • 9:00 AM EDT

Amarantus to Present at 6th Annual Livingston Securities Life Science Stakeholders Summit

October 14, 2013 • 12:09 PM EDT

Amarantus Announces Positive Analytical Performance Data for LymPro Test(R) for Alzheimer's Disease